Applications of 1-(2-Benzyloxy-Ethyl)-Piperazine in Industrial Manufacturing

As a direct producer, we support multiple high-value synthesis processes with our 1-(2-Benzyloxy-Ethyl)-Piperazine. This intermediate has established usage in pharmaceutical manufacturing, agrochemical synthesis, and advanced materials, with formulation and integration relying on its specific molecular reactivity and compatibility across different end products.

1. Pharmaceutical API Intermediate for Antipsychotic Compounds

Our material plays a direct role in the multi-step production of antipsychotic active pharmaceutical ingredients (APIs), particularly where piperazine rings with customized side chains are critical for pharmacological targeting. Customers use it during the construction of API scaffolds, benefiting from the stability and reactivity profile which supports selective N-alkylation steps while maintaining drug substance purity levels mandated for regulatory approval in major markets.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) Monographs for API intermediates
• US FDA 21 CFR Part 211 Finished Pharmaceuticals requirements
• Japanese Pharmacopoeia (JP) for API precursors

Typical usage ratio

• 0.8–1.2 molar equivalents relative to core scaffold, adjusted according to reagent conversion efficiency and target impurity profiles

Downstream process integration

• Reactant enters the synthetic route during the N-alkylation of precursor heterocycles and is subsequently purified via chromatography or crystallization prior to final API coupling steps

Final product types

• Antipsychotic bulk APIs
• Neuroleptic formulation intermediates
• Finished oral solid dosage pharmaceutical forms (tablets and capsules)
• Regulatory submission-grade intermediate reference standards

2. Key Intermediate in Agrochemical Fine Synthesis

Agrochemical manufacturers use our compound as a building block for targeted piperazine-based fungicide and herbicide actives, where its benzyloxy-ethyl functionalization allows precise side chain incorporation. Its reactivity enables coupling reactions necessary for next-generation crop protection agents, often supporting high reaction yields while limiting unwanted byproducts per environmental compliance rules in the agchem sector.

Industry compliance standards

• FAO/WHO Codex Alimentarius for pesticide active ingredient purity
• EU Regulation (EC) No 1107/2009 for placing plant protection products on the market
• China GB/T 1600 agrochemical standard
• OECD GLP requirements for raw material traceability

Typical usage ratio

• 10–18% by mass in active ingredient synthesis batch; exact proportion is optimized per downstream molecule’s yield and regulatory residue limits

Downstream process integration

• Added during substrate coupling and side-chain elongation steps; intermediates further processed via chlorination or further cyclizations to obtain final pesticide actives

Final product types

• Systemic fungicide actives
• Herbicide technical concentrates
• Protectant premix intermediates
• Commercial agrochemical technical-grade products

3. Intermediate for CNS Drug Discovery and Development

Customers developing novel central nervous system (CNS) agents rely on this material for constructing candidate molecules that interact with dopamine and serotonin receptors, as the benzyloxy-ethyl modification offers binding selectivity not accessible with simpler piperazines. Used both in medicinal chemistry screenings and pilot-scale clinical sample synthesis, the material supports lead diversification and structure-activity exploration.

Industry compliance standards

• ICH Q11 Development and Manufacture of Drug Substances
• US FDA Guidance for Industry: IND Applications for Early Phase Clinical Trials
• European EMA Clinical Trial Regulation (EU) No 536/2014
• OECD Guidelines for the Testing of Chemicals (medicinal chemistry safety assessment)

Typical usage ratio

• 1.0–1.5 equivalents depending on required substitution pattern; adjusted during scale-up optimization to minimize side product formation and ensure batch-to-batch uniformity

Downstream process integration

• Introduced during the amination or alkylation reaction phase; processed via analytical purification (HPLC, LC-MS) before submission to in vitro/in vivo pharmacological assays

Final product types

• Screening libraries for CNS modulators
• Pilot batch clinical drug candidates (Phase I/II)
• Reference compounds for bioanalytical method validation
• Intermediate stock solutions for preclinical studies

4. Synthesis of Specialty Polymer Modifiers

Manufacturers of advanced polymers and resin modifiers use this molecule to introduce functional amine groups that facilitate cross-linking and compatibility in specialty coatings and adhesives. The benzyloxy-ethyl group supports dispersion in organic polymer matrices, while the piperazine ring’s nucleophilicity enables further functionalization during post-polymerization modification processes.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems for industrial polymers
• REACH (EC 1907/2006) registration for industrial chemicals
• ASTM D3453 for polymeric materials used in electronics
• RoHS Directive 2011/65/EU for restricted substances in electronics polymers

Typical usage ratio

• 1–5% by weight depending on end-use properties desired for the polymer or coating system; tuning based on required degree of cross-linking and processing temperature

Downstream process integration

• Directly blended during resin synthesis or post-polymerization treatment; functional groups may be activated via acid chloride or isocyanate chemistry in coatings applications

Final product types

• Epoxy and polyurethane cross-linking agents
• Specialty adhesives for electronics
• Polymer coatings with tailored surface characteristics
• Industrial binder systems for advanced composites

5. Precursor for Functionalized Bioconjugation Reagents

Producers engaged in bioconjugation and diagnostic reagent manufacturing select this raw material for synthesizing amine-reactive linkers. Its piperazine framework, combined with the benzyloxy-ethyl group, allows for site-specific attachment of labels or biomolecules, supporting downstream preparation of affinity probes and diagnostic assay tools with enhanced stability and specificity.

Industry compliance standards

• ISO 13485:2016 for medical devices and diagnostic reagents
• USP General Chapter <1047> for analytical reagents
• OECD Principles of Good Laboratory Practice (GLP) for diagnostic chemicals
• REACH Annex XIV for chemical safety in laboratory environments

Typical usage ratio

• 0.5–5 mol% in linker synthesis relative to activated ester content; levels vary based on desired probe loading and assay sensitivity targets

Downstream process integration

• Introduced during amine activation or derivatization step; products further purified by preparative chromatography before coupling to peptides, proteins, or reporter molecules

Final product types

• Affinity labels for immunoassays
• Technical reagents for bioanalytical research
• Biotinylated conjugation agents
• Fluorescent and chromogenic tagging compounds